Patient Derived Xenograft/PDX Models
Global Patient Derived Xenograft / PDX Models Market to Reach $333.2 Million by 2027
In the changed post COVID-19 business landscape, the global market for Patient Derived Xenograft / PDX Models estimated at US$115.7 Million in the year 2020, is projected to reach a revised size of US$333.2 Million by 2027, growing at aCAGR of 16.3% over the period 2020-2027. Mice Model, one of the segments analyzed in the report, is projected to record 17.7% CAGR and reach US$255 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Rat Model segment is readjusted to a revised 12.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $33.4 Million, While China is Forecast to Grow at 15.3% CAGR
The Patient Derived Xenograft / PDX Models market in the U.S. is estimated at US$33.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$56.9 Million by the year 2027 trailing a CAGR of 15.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.9% and 13.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.7% CAGR.
Select Competitors (Total 38 Featured) -
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook